SCHEMBL17375771

SCHEMBL17375771

CCC1NC=Cc2cc(OCc3ccccc3)c(OC)cc21

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
HSD17B10 Q99714 2/20 0.42
MAPK1 P28482 1/20 0.42
HPGD P15428 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
SIRT2 Q8IXJ6 1/20 0.42
CTSV O60911 1/20 0.41
CTSL P07711 1/20 0.41
SRD5A1 P18405 1/20 0.41
SRD5A2 P31213 1/20 0.41
CHRNA7 P36544 2/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
ALDH1A1 P00352 1/20 0.40
MAPT P10636 1/20 0.40
KDM4C Q9H3R0 1/20 0.40
APP P05067 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8747158 0.72 MEN1 (0.36) SMN1; SMN2SIRT2CHRNA7MEN1KMT2A
Hydrochloric Acid SCHEMBL11639609 0.72 CA2 (0.44) HSD17B10MAPK1ALDH1A1
SCHEMBL8556952 0.69 MEN1 (0.60) NPC1RAB9AHSD17B10HPGDSMN1; SMN2
SCHEMBL8554816 0.69 MAPK1 (0.59) NPC1RAB9AHSD17B10MAPK1SMN1; SMN2
SCHEMBL8554822 0.68 MAPK1 (0.64) NPC1RAB9AHSD17B10MAPK1HPGD
SCHEMBL5653057 0.68 NPC1 (0.64) NPC1RAB9AHSD17B10MAPK1HPGD
SCHEMBL29993463 0.67 CHRNA7 (0.45) NPC1RAB9AHSD17B10MAPK1HPGD
SCHEMBL11718272 0.67 KMT2A (0.79) MAPK1CHRNA7MEN1KMT2AALDH1A1
SCHEMBL18721789 0.67 SIRT2 (0.42) HSD17B10SIRT2CTSVCTSLSRD5A1
SCHEMBL3051394 0.66 CHRNA7 (0.50) NPC1RAB9AHSD17B10MAPK1CHRNA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015197550-A1 NOVEL DIHYDROPYRIDOISOQUINOLINONES AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF INFLAMMATORY DISORDERS GALAPAGOS NV (BE) 2015-12-30 WO disclosed